Century Therapeutics, Inc. (IPSC) — Operating Income
| Fiscal Year | Operating Income | Change YoY |
|---|---|---|
| 2025 | -$17.27M | +87.5% |
| 2024 | -$138.14M | +5.7% |
| 2023 | -$146.55M | -9.5% |
| 2022 | -$133.83M | -41.0% |
| 2021 | -$94.88M | -76.0% |
| 2020 | -$53.90M | — |
| Fiscal Year | Operating Income | Change YoY |
|---|---|---|
| 2025 | -$17.27M | +87.5% |
| 2024 | -$138.14M | +5.7% |
| 2023 | -$146.55M | -9.5% |
| 2022 | -$133.83M | -41.0% |
| 2021 | -$94.88M | -76.0% |
| 2020 | -$53.90M | — |